Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **biofilm matrix on wound surface** refers to the extracellular matrix, primarily composed of polysaccharides, extracellular DNA, proteins, and lipids, secreted by microbial communities adhering to wound beds[1][2][3][5][7]. This matrix physically encases and protects bacteria and other microorganisms, forming a structured, three-dimensional network that impairs host immune defenses, reduces antibiotic penetration, and facilitates chronic infection[1][2][4][5][6][7]. The biofilm matrix is a major barrier to healing in chronic wounds, requiring targeted disruption (e.g., by specific cleansers or dressings) for effective treatment. The composition and structure of the matrix can vary, but its principal functions are to support microbial survival, promote aggregation, and defend against hostile environmental factors, including medical therapies and host immunity[1][3][4][5][7].
Chemical disruption of matrix polysaccharides; Enhanced accessibility of antimicrobials via matrix breakdown; Mechanical removal after matrix destabilization
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biofilm matrix on wound surface.